Literature DB >> 2372379

Heterosexual behaviour of intravenous drug users in Amsterdam: implications for the AIDS epidemic.

A van den Hoek1, H J van Haastrecht, R A Coutinho.   

Abstract

In order to assess the potential role of intravenous drug users (IVDUs) in Amsterdam in the heterosexual transmission of HIV, we studied the sexual behaviour of 243 male and female IVDUs with regard to their private ('steady' and 'casual') and commercial partners. The majority of the study group appear heterosexually active, especially female IVDUs, who often have commercial as well as one or more private partners. Vaginal contact is the most frequent method of sexual contact; condoms are used infrequently with private partners but much more frequently with commercial partners. A history of sexually transmitted disease is common, not only among IVDU prostitutes but also among IVDUs without a history of prostitution. IVDUs who know that they are HIV-infected reported fewer commercial partners and more frequent condom use with private partners than IVDUs who are negative or do not know their test result. We conclude that IVDUs may form an important source for heterosexual transmission of HIV. Voluntary testing of IVDUs on a large scale, together with intensive counselling, may slow down the further spread of HIV from infected IVDUs to their private and commercial partners, but is unlikely to stop heterosexual transmission completely.

Entities:  

Mesh:

Year:  1990        PMID: 2372379     DOI: 10.1097/00002030-199005000-00011

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  13 in total

1.  Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users.

Authors:  M G Schlumberger; J C Desenclos; G Papaevangelou; S C Richardson; R Ancelle-Park
Journal:  Eur J Epidemiol       Date:  1999-03       Impact factor: 8.082

Review 2.  STD control in drug users and street youth.

Authors:  A van den Hoek
Journal:  Genitourin Med       Date:  1997-08

3.  Determinants of current HIV risk behaviour among injecting drug users in Warsaw, Poland.

Authors:  K Stark; J Sieroslawski; R Müller; D Wirth; C Godwod-Sikorska; U Bienzle
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

4.  Cost-effectiveness of HIV counseling and testing in US prisons.

Authors:  B Varghese; T A Peterman
Journal:  J Urban Health       Date:  2001-06       Impact factor: 3.671

5.  ASSOCIATION BETWEEN HIV KNOWLEDGE AND RISK BEHAVIOR IN PERSONS WHO INJECT DRUGS IN THAI NGUYEN, VIETNAM.

Authors:  Travis W Lim; Wendy W Davis; Vu Minh Quan; Constantine Frangakis; Tran Viet; Nguyen Le Minh; Carl Latkin; Carla Zelaya; Tran Thi Mo; Vivian F Go
Journal:  Southeast Asian J Trop Med Public Health       Date:  2014-11       Impact factor: 0.267

6.  Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users.

Authors:  D A Calsyn; A J Saxon; G Freeman; S Whittaker
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

7.  HIV infection, risk behaviors, and depressive symptoms among Puerto Rican sex workers.

Authors:  M Alegría; M Vera; D H Freeman; R Robles; M C Santos; C L Rivera
Journal:  Am J Public Health       Date:  1994-12       Impact factor: 9.308

8.  Condom use and sexual habits of heterosexual intravenous drug users in northern Italy.

Authors:  D Serraino; S Franceschi; E Vaccher; S Diodato; D Errante; I Crosato; S Guarneri; U Tirelli
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

9.  Sexually transmissible diseases in injecting drug users.

Authors:  M W Ross; J Gold; A Wodak; M E Miller
Journal:  Genitourin Med       Date:  1991-02

10.  HIV prevalence among clients attending a sexually transmitted diseases clinic in Amsterdam: the potential risk for heterosexual transmission.

Authors:  J S Fennema; E J van Ameijden; R A Coutinho; G J van Doornum; C J Henquet; J A van den Hoek
Journal:  Genitourin Med       Date:  1993-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.